Quarterly and Half Year due by April 30.
https://www.asx.com.au/documents/research/company-reporting-dates-2018.pdf
Was sniffing around for anything that references EBOS, Terry White and MedAdvisor and found the below from late February. Headline reads - Big year for pharmacy leader
https://ajp.com.au/news/mixed-bag-pharmacy-leader/
During the first half, we have fully transitioned HPS into the Group, further expanding our leading position in the Institutional Healthcare market. In October, we acquired a strategic 14.1% shareholding in MedAdvisor Ltd, Australia’s leading digital medication management company.
Will Management simply report the mandatory quarterly and full year numbers or will there be a big bang announcement showing some bottom line revenue from hospital integration with EBOS and/or international interest?
Volume is drying up. If the numbers are good and the update shows progress, then we can assume the lack of interest was the spring getting tighter. If organic growth is stale and integration is lagging, then I won't be surprised if we drift back to under 4 cents. Let's hope Management can clearly articulate what they've been doing over the last 6 months and where the rest of 2018 is positioned..........
Add to My Watchlist
What is My Watchlist?
